about
Efficacy and safety of traditional chinese medicine for diabetes: a double-blind, randomised, controlled trial10-year follow-up of intensive glucose control in type 2 diabetesA Bayesian Modelling Approach with Balancing Informative Prior for Analysing Imbalanced Data.Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT)Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.The association between body mass index and mortality in incident dialysis patients.Intensive glucose control and macrovascular outcomes in type 2 diabetes.Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational studyOrthosis-Shaped Sandals Are as Efficacious as In-Shoe Orthoses and Better than Flat Sandals for Plantar Heel Pain: A Randomized Control Trial.Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patientsDisease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial.Promoting Activity in Geriatric Rehabilitation: A Randomized Controlled Trial of Accelerometry.Effect of educational outreach on general practice prescribing of antibiotics and antidepressants: a two-year randomised controlled trialTrajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort.Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.The Foot Orthoses versus Hip eXercises (FOHX) trial for patellofemoral pain: a protocol for a randomized clinical trial to determine if foot mobility is associated with better outcomes from foot orthoses.Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in PrediIncorporating teledermatology into emergency medicine.Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma.Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?Genetic and Clinical Predictive Factors of Sulfonylurea Failure in Patients with Type 2 Diabetes.Screening for delirium within the interRAI acute care assessment system.Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients.A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.Comparison of trajectories of self-monitored glucose levels by hypoglycemia status over 52 weeks of treatment with insulin glargine or exenatide once weekly.Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.Three-year efficacy of complex insulin regimens in type 2 diabetes.Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: a retrospective study.Analysis of bedside entertainment services' effect on post cardiac surgery physical activity: a prospective, randomised clinical trial.Impact of comorbid diabetes on quality of life and perception of angina pain in people with angina registered with general practitioners in the UK.Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*.Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.Comparison of body mass index at diagnosis of diabetes in a multi-ethnic population: A case-control study with matched non-diabetic controls.Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
P50
Q28487001-27D36319-07B3-4E24-8C33-647A9D1B2B66Q29615973-29F664D0-B0C8-41C4-A90C-62081E14FA5BQ31075196-1658EFD2-C2C2-45B8-B96D-140417F68452Q33766283-44929DCF-9B63-4BDA-96F0-3B0C4CE3BCF2Q34448684-3D6687B8-0F25-427B-A4DF-E67D89A5AB05Q34692143-C43928A3-78B4-44CF-808D-4E0BBBB2FE30Q34712804-EC61F873-5FA2-4A60-B2CF-459B37A3C9EBQ34995674-8EF06528-7C1E-4384-842E-46AD695F33D5Q35030247-EEF5075F-BAC6-4517-AB0E-1F639855B5FDQ35041308-5491E80C-B86E-4F3A-81A2-3B306BB5C69FQ35869079-55428736-D522-4DF3-8483-4811F0E9EA3DQ35927578-769001FD-2993-488E-8BE8-8EB85E121240Q35942407-9FD65868-A16A-431A-B538-14F9D8ED8F96Q36057220-D8CFC99D-C6F4-4D42-BB10-C00DDBE5C871Q36114314-E23D84C2-A07E-4E58-8803-98FE58BD8021Q36147560-C1C0BEA3-303E-4C03-8A8F-98ED102394D1Q37065251-B7B4CC7E-9B36-4DB7-80D7-21F807F76968Q37345822-991351C9-2925-4110-8C30-BC4ED5F81F2EQ37604652-C6C69D9D-C0B1-4BC7-8BAC-64232FDE807DQ37607425-12989CD1-FA99-4F56-918A-8B48B82DE292Q37945278-8728EBED-A6FE-4FFB-BEC8-D7EE929880E6Q38191274-946E7275-13AF-4A96-AADA-7326474FC2C5Q38800986-5EF0835F-3763-4AA5-8E84-D8058AF50A54Q39610528-0B0853E2-9853-466D-9468-505269ACF38CQ40069631-15862AD5-6D26-4547-8F41-06E0CBE26E69Q40536743-48F6F3EE-CAEF-4F9D-8626-8C3CCABEE8D3Q40709270-77A8F5F0-9792-4DEE-A403-47BBF7626834Q41586046-00836FAD-2C66-40A9-A0D0-F25A2FBD0B06Q41709013-F38EB109-D993-4050-81FF-B86DD032C16CQ42841671-A92A4337-94F4-4F3A-AD23-93DE4708ED28Q43256453-D40C4DB2-1D40-4945-9BBA-D0A844D10228Q43514338-76C2F245-A7BC-40EA-B65B-FDE365188F6FQ43553202-226570B7-8A00-4ACA-8E87-CD33E6C011F4Q44569165-2F48709B-25C4-42AF-A082-917358A2F09AQ44888992-EA40E987-A775-4B18-A334-478172A0C521Q45347830-4FE51062-AF54-4CDF-A03C-0FEFBD4609F7Q45376082-66674BC9-A22D-4ECF-9806-0517BB5FCFB7Q46252246-3DAEA887-32EA-4060-B55E-62F9C88B837FQ46438627-733E38A5-B2DF-4071-AF8E-063D94E0F6A5Q48356528-F9C78205-E09C-4DA7-AEA3-4474FA7D320B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sanjoy K. Paul
@ast
Sanjoy K. Paul
@en
Sanjoy K. Paul
@es
Sanjoy K. Paul
@sl
type
label
Sanjoy K. Paul
@ast
Sanjoy K. Paul
@en
Sanjoy K. Paul
@es
Sanjoy K. Paul
@sl
prefLabel
Sanjoy K. Paul
@ast
Sanjoy K. Paul
@en
Sanjoy K. Paul
@es
Sanjoy K. Paul
@sl
P108
P1053
F-8199-2010
P106
P1153
55936459500
P21
P31
P3829
P496
0000-0003-0848-7194